Gut Bacterium Sugar Promotes Visceral Fat Burning in Early Research
Researchers identified a modified sugar from Clostridium immunis that triggers energy expenditure in visceral fat cells without altering food intake.
What the Researchers Discovered
Researchers from Duke-NUS Medical School and Duke University School of Medicine identified a gut bacterium that produces a modified sugar molecule capable of stimulating energy burning in visceral fat.
The organism, named Clostridium immunis (C. immunis), manufactures an exopolysaccharide (EPS) that requires an attached chemical group called phosphocholine to function.
In laboratory models, this phosphocholine-modified sugar reduced weight gain and decreased visceral fat, which surrounds internal organs and links to cardiovascular disease and type 2 diabetes.
How the Molecule Triggers Visceral Fat Burning
The bacterial sugar increases energy expenditure in visceral fat by altering local immune signals without changing calorie consumption or physical movement.
The investigation showed that phosphocholine-modified EPS lowered levels of interleukin-22 (IL-22), an immune signaling protein that coordinates communication between the gut lining and nearby adipose tissue.
Reducing IL-22 increased the abundance of cells expressing uncoupling protein 1 (UCP1), a mitochondrial protein that directs fat cells to release stored calories as heat.
Population Data Links the Gene to Lower Body Weight
An evaluation of human genomic databases showed that individuals with obesity carry fewer copies of the bacterial gene required to attach phosphocholine to the sugar molecule.
The investigators analyzed published metagenomic records from 4,145 individuals across multiple countries.
Individuals with a body mass index (BMI) below 25 maintained higher counts of this modification gene than individuals classified with obesity.
Clinical Trial Plans and Current Limitations
The findings represent early laboratory research, meaning researchers have not yet tested C. immunis or its modified sugar in human clinical trials.
The study authors have secured a patent on C. immunis and the associated EPS molecule, with plans to begin clinical trials in the United States (U.S.) to evaluate therapeutic potential.
Because commercial formulations of this bacterium do not exist, patients managing visceral fat or insulin resistance should consult a clinician regarding established nutritional and lifestyle interventions.
What to Look For in a Body-Composition Scale
A bioimpedance scale trends body fat and muscle rather than just weight — useful when the number stalls but your composition is improving. The absolute body-fat % isn't lab-accurate, so use it for TRENDS at a consistent time of day. Choose one that syncs to an app so you can watch the trend line.


Related Articles
Studying Energy Use for Personalized Weight-Loss Treatments
University of Alberta researchers are studying metabolic adaptation in whole-room calorimeters...
Read article MetabolismHyperpolarized MRI Tracks Liver Enzyme Activity in Fatty Liver
A preclinical study in Sensors & Diagnostics demonstrates a specialized MRI method that maps...
Read article MetabolismGuidance Outlines Eating Disorder Screening for GLP-1 Drugs
Clinical guidance in World Psychiatry outlines screening and safety practices for prescribing...
Read article MetabolismTwo Understudied PFAS Linked to Higher Liver Cancer Risk
Blood levels of two newer PFAS compounds doubled liver cancer odds in a USC study, with the...
Read articleWant medical weight loss instead of another diet?
Opt Health prescribes and monitors GLP-1 therapy against real labs — insulin, A1C, lipids, thyroid, hormones — so the plan fits your physiology rather than a generic protocol. Medication ships to your door.
See Opt Health's weight-loss program →Topic updates
Get the weekly metabolic health roundup
Insulin resistance, blood sugar, visceral fat, GLP-1 plateaus, metabolic syndrome, and weight-loss physiology.
Understand Your Health Better
Our free assessment maps your symptoms to the most relevant guides, tools, and product recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results
Affiliate disclosure: The Metabolic Journal is reader-supported. Some links above are affiliate or referral links and we may earn a commission at no extra cost to you. Products are chosen on the merits; commissions never influence what we recommend. This is general information, not medical advice — talk to your clinician before acting.